In VitroCellular Tropism of Human T Cell Leukemia Virus Type 2
- 1 November 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 16 (16) , 1661-1668
- https://doi.org/10.1089/08892220050193119
Abstract
Human T cell leukemia virus type 1 (HTLV-1) and 2 (HTLV-2) are distinct oncogenic retroviruses that infect several cell types, but display their biologic/pathogenic activity only in T lymphocytes. HTLV-1 is associated with adult T cell leukemia, a malignancy of mature CD4+ T cells, and a chronic neurological disorder termed HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-2 is less pathogenic and has been associated with a few cases of a variant of hairy cell leukemia and neurological disease. Previous studies have indicated that in vivo HTLV-1 has a preferential tropism for CD4+ T cells, whereas HTLV-2 in vivo tropism is less clear, but appears to favor CD8+ T cells. The molecular mechanism that determines the cellular tropism of HTLV-1 and HTLV-2 has not been precisely determined. However, one study by our group has provided evidence that HTLV-1-enhanced viral transcription in CD4+ T cells may be responsible for its tropism. In an effort to understand HTLV-2 tropism we tested the ability of HTLV-2 to infect, replicate in, and transform purified CD4+ or CD8+ T cells in cell culture. After cocultures of purified primary human CD4+ and CD8+ T cells with an HTLV-2-producer cell line we measured viral transcription by reverse transcription PCR analysis, virus production by p19gag ELISA, proviral integration by DNA slot-blot analysis, surface phenotype by FACS analysis, and cellular transformation. We also measured HTLV-2 long terminal repeat-directed transcription in the presence and absence of Tax in purified CD4+ and CD8+ T cells, using transient transfection assays. Our data indicate that CD4+ and CD8+ T cells are equally susceptible to HTLV-2 infection. We observed no significant difference in viral transcription based on mRNA and virus production in CD4+ and CD8+ T cell cocultures. Although LTR transcription was enhanced 12- to 16-fold in the presence of Tax, there was no significant difference in CD4+ or CD8+ T cells. Interestingly, we show that HTLV-2 preferentially transforms CD8+ T cells in culture. Together, our data indicate that, unlike HTLV-1, HTLV-2 cell tropism is not due to inhibition of viral infection and inefficient gene expression in CD4+ versus CD8+ T cells, and likely involves unique interactions with viral and CD8+ T cell-specific proteins.Keywords
This publication has 35 references indexed in Scilit:
- Constitutively Activated Jak-STAT Pathway in T Cells Transformed with HTLV-IScience, 1995
- In Vivo Cellular Tropism of Human T-Lymphotropic Virus Type II Is Not Restricted to CD8+ CellsVirology, 1995
- In Vivo Infection of Human T-Cell Leukemia Virus Type I in Non-T CellsVirology, 1993
- Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction.Proceedings of the National Academy of Sciences, 1992
- Infectivity of human T-lymphotropic virus type I to human nervous tissue cells in vitroActa Neuropathologica, 1992
- In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II).The Journal of Experimental Medicine, 1992
- Chronic neurodegenerative disease associated with HTLV-II infectionThe Lancet, 1992
- A Second Isolate of HTLV-II Associated with Atypical Hairy-Cell LeukemiaNew England Journal of Medicine, 1986
- Molecular characterization of genome of a novel human T-cell leukaemia virusNature, 1983
- A New Subtype of Human T-Cell Leukemia Virus (HTLV-II) Associated with a T-Cell Variant of Hairy Cell LeukemiaScience, 1982